| 000 | 01089 a2200313 4500 | ||
|---|---|---|---|
| 005 | 20250515074228.0 | ||
| 264 | 0 | _c20071024 | |
| 008 | 200710s 0 0 eng d | ||
| 022 | _a2694-233X | ||
| 024 | 7 |
_a10.1377/hlthaff.26.4.1198-a _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aCopeland, Kennon R | |
| 245 | 0 | 0 |
_aBrand-name versus generic. _h[electronic resource] |
| 260 |
_bHealth affairs (Project Hope) _c |
||
| 300 |
_a1198-9; author reply 1199 p. _bdigital |
||
| 500 | _aPublication Type: Comment; Letter | ||
| 650 | 0 | 4 |
_aCost Savings _xmethods |
| 650 | 0 | 4 |
_aDrug Costs _xstatistics & numerical data |
| 650 | 0 | 4 |
_aDrug Industry _xeconomics |
| 650 | 0 | 4 |
_aDrugs, Generic _xeconomics |
| 650 | 0 | 4 | _aEconomic Competition |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aMedicaid _xeconomics |
| 650 | 0 | 4 | _aModels, Econometric |
| 650 | 0 | 4 | _aUnited States |
| 700 | 1 | _aBoccuzzi, Stephen J | |
| 773 | 0 |
_tHealth affairs (Project Hope) _gvol. 26 _gno. 4 _gp. 1198-9; author reply 1199 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1377/hlthaff.26.4.1198-a _zAvailable from publisher's website |
| 999 |
_c17165381 _d17165381 |
||